Objective: The objective of this systematic review was to answer the question: what is the evidence for the effectiveness of prenatal versus postnatal closure of MM regarding short and long-term ambulatory status. Treatment recommendations were provided based on the available evidence.
Methods:
The National Library of Medicine PubMed database and Embase were queried using MeSH headings and keywords relevant to ambulatory status after prenatal or postnatal closure of MM. Abstracts were reviewed to identify which studies met the inclusion criteria. An evidence table was assembled summarizing the studies and the quality of evidence (Classes I-III). Based on the quality of the literature, a recommendation was rendered (Level I, II, or III). 
Recommendation(s)
1. When possible, for prenatally diagnosed fetuses with myelomeningocele who meet maternal and fetal MOMS study inclusion criteria, prenatal closure of myelomeningocele should be performed, which may improve ambulatory status for patients in the short term (at 30 months of age) (Level II).
2. Long term benefit for ambulatory status with prenatal closure is unknown. Children who have had either prenatal or postnatal closure should be carefully followed for the development of tethered spinal cord with the associated loss of ambulatory function (Level III).
INTRODUCTION

Rationale
Myelomeningocele (MM), or open neural tube defect, is a condition often diagnosed prenatally with fetal ultrasound or maternal blood test. The current incidence of MM is approximately 3 per 10,000 live births (CDC), with around 1,500 babies born with spina bifida (SB) each year in the United States. 1 The incidence was much higher prior to the United States' government recommendations in 1992 and 1996 to supplement women's diet with folic acid. 
Objectives
The objective of this systematic review is to evaluate the effect of prenatal closure compared to postnatal closure of the neural placode on the ability to ambulate in patients born with MM. Intended users of these guidelines include medical professionals who treat patients with MM, including providers in the prenatal setting who provide counseling treatment options and those in the postnatal setting regarding prognosis.
METHODS
Writing Group and Question Establishment
The Guidelines Task Force initiated a systematic review of the literature and evidencebased guideline relevant to the diagnosis and treatment of patients with MM. Through objective evaluation of the evidence and transparency in the process of making recommendations, this evidence-based clinical practice guideline was developed for the diagnosis and treatment of patients with MM. These guidelines are developed for educational purposes to assist practitioners in their clinical decision-making processes. Additional information about the methods utilized in this systematic review is provided in the introduction and methodology chapter. The topic of ambulatory status after prenatal or postnatal closure of MM was chosen because of the need to provide better guidance to our patients who present for prenatal counseling for this condition.
Literature Search
The task force members collaborated with a medical librarian to search the National Library of Medicine PubMed database and Embase for the period from 1966 to September 2016 using the search strategies provided in Appendix I. The literature search yielded 30 abstracts.
The task force selected 4 full-text articles for review. Of these, none were rejected for not meeting inclusion criteria or for being off-topic. All 4 articles were selected for systematic review (see Appendix II).
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Study Selection and Eligibility Criteria
A total of 30 citations were manually reviewed by the task force with specific inclusion and exclusion criteria as outlined below. Two independent reviewers evaluated and abstracted full-text data for each article, and the 2 sets of data were compared for agreement by a third party. Inconsistencies were re-reviewed, and disagreements were resolved by consensus.
Citations that considered pediatric patients with prenatal or postnatal MM closure and evaluated later ambulation status were reviewed. To be included in this guideline, an article must be a report of a study that:
• At least 80% of patients had to be patients with MM and <18 years of age.
• Studies that enrolled >20% of patients with other forms of SB were excluded.
• Studies that combined the results of patients with other forms of SB were excluded if the study enrolled less than 80% of target patient population.
• Studies that enrolled mixed patient populations were included only if they reported separate results for the target population. The results of the target population were the only results considered as evidence to support our recommendations.
• The study was a full article report of a clinical study.
• The study was not a meeting abstract, editorial, letter, or a commentary.
• Prospective case series had to report baseline values, if applicable.
• Case series studies with non-consecutive enrollment of patients were excluded.
• Studies had to have appeared in a peer-reviewed publication or a registry report.
• Studies had to enroll at least 10 patients for each distinct outcome measured. If it was a comparative study, a minimum enrollment of 5 patients per treatment arm for each outcome was necessary.
• The study involved humans.
• The study was published between January 1966 and September 2016.
• The study presented results quantitatively.
• The study did not involve "in vitro", "biomechanical" or results performed on cadavers.
• The study was published in English.
• Papers reporting results of systematic reviews, meta-analyses, or guidelines developed by others were excluded.
• Authors specifically excluded follow-up studies in which a cohort of patients from an initial study were followed in time and separately reported upon in a subsequent publication. This prevented the same patients from being included multiple times in this review.
The authors did not include systematic reviews, guidelines, or meta-analyses conducted by others.
Data Collection Process
The abstracts that met the selection criteria mentioned above were retrieved in full-text form. Each article's adherence to the selection criteria was confirmed. To determine how the data could be classified, the information in the full-text articles was then evaluated to determine whether they were providing results of therapy or were more centered on diagnostic or prognostic information. Agreement on these assessments and on the salient points regarding the type of study design and objectives, and the conclusions and data classification was then reached by exchanging drafts and comments by e-mail and discussing questions during monthly phone conference among participants. The information was then used for construction of the evidence tables.
Assessment for Risk of Bias
The literature included in full text review was assessed for risk of bias. The methodological quality of the one randomized controlled trial (RCT) was evaluated using the following 6 criteria: sequence generation, allocation concealment, blinding, incomplete reporting of data, selective reporting of outcomes, and evaluation for other potential threats to validity.
Retrospective case series were assessed for bias by evaluating for selective reporting bias, lack of or loss of information over time, publication bias, bias resulting from a retrospective study, and other types of bias.
Rating Quality of Evidence
The quality of evidence was rated using an evidence hierarchy for 2 different study types; 
Revision Plans
In accordance with the Institute of Medicine's standards for developing clinical practice guidelines, the task force will monitor related publications following the release of this document and will revise the entire document and/or specific sections "if new evidence shows that a recommended intervention causes previously unknown substantial harm; that a new intervention is significantly superior to a previously recommended intervention from an efficacy or harms perspective; or that a recommendation can be applied to new populations." 6 In addition, the task force will confirm within 5 years from the date of publication that the content reflects current clinical practice and the available technologies for prenatal versus postnatal closure of MM.
RESULTS
Study Selection and Characteristics
Literature search found 30 abstracts, 4 of which were chosen for full text review. The other 26 articles were not pertinent to the question or only existed as abstracts. Evaluation of references from these 4 articles found no further primary sources for review. After full text review, all 4 articles were included (see Appendix IV).
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Results patients who could ambulate at some point, and the age at which they began to ambulate and stopped being able to ambulate. Data was presented by level of neural tube defect. One hundred seventy three children were evaluated for their ability to ambulate, with or without assistive devices. Thirty-five children had a thoracic level lesion. Seven walked at mean age 4 years 6 months, and 3 of these children stopped walking at mean age 7 years 6 months. Ten children had a high-lumbar lesion. Five patients walked at mean age 5 years 2 months, and 3 of these patients stopped walking at mean age 6 years 11 months. Fifteen children had mid-lumbar level lesion.
Nine patients walked at mean age 5 years, and 3 of these patients stopped walking at mean age 7
years. Forty-five children had low lumbar level lesion. Thirty-eight patients walked at mean age 3 years 10 months, and five of these patients stopped walking at mean age 9 years 1 month.
Sixty-eight children had sacral lesions. All patients walked at average age 2 years 2 months, and none had stopped walking at the end of the study period. 
DISCUSSION
In this systematic review of the literature, authors found that prenatal closure of MM provided improved motor function level and improved ambulatory status as compared to children who underwent postnatal closure of MM. It is unknown whether these findings are maintained long term due to the potential detrimental effects of future spinal cord tethering in these patients.
The Adzick et al. 2 (2011) study found that prenatal closure provided on average a level of function 2 or more levels better than the anatomic level of the neural tube defect. Study patients were more likely to walk without orthotics or other assistive devices. Potential bias comes from lack of randomization of study patients by neural tube defect level and from the post hoc analysis evaluating motor findings, which were not part of the initial outcomes measures. In addition, motor function was evaluated only once at 30 months of age, which limits applying this study to long term ambulatory function in these children. A difference in the rate of re-tethering between cohorts could significantly impact long term ambulatory function.
The Danzer et al. 3 (2016) study found that in this cohort of prenatally closed patients, 79% were community ambulators at an average 10 year follow up. This is similar to the 71% of patients in the MOMS study who could ambulate either unassisted or with an assistive device at 30 month follow up. This provides some evidence of the durability of the effect of prenatal closure on ambulatory status. The risk of tethering was 3 of 42 patients (7.1%) which is a similar rate of tethering to other studies in the literature. Bias is assumed because these patients were not followed through skeletal maturity. Patients often exhibit symptoms of tethering during periods of skeletal growth. An average of 10 years follow up misses the teenage years and typical accelerated growth during puberty. If the rate of tethering increases during puberty, this could change this long-term ambulatory status for these patients.
The Williams et al. 5 (1999) study found that lower anatomic lesions provided an increased chance a child would be able to ambulate, with or without assistive devices. The study shows that some children may be able to ambulate at a young age, but the child may stop ambulating when the child gets older. The study did not evaluate for reasons for this phenomenon, however the discussion hypothesizes it may include a combination of reasons for a changing body habitus as the child grows older that might prevent ambulation, including weight gain, scoliosis, orthopedic deformity, or even possibly spinal cord tethering. Spinal cord tethering is not specifically addressed in this manuscript. Another potential bias of this study is that the series includes diagnosis of MM, lipomyelomeningocele, and intraspinal lipoma.
Another bias is that there was no specific evaluation of the incidence or rate of spinal cord tethering in these patients.
The Januschek et al. 4 (2016) study found that 70% of their postnatally closed patients were able to ambulate with or without assistive device at the time of their assessment. This number is higher than the postnatal closure group in the MOMS study, 2 however there is potential bias because the assessment was performed retrospectively and there was no specific timepoint when ambulatory status was assessed for every patient. Spinal cord tethering was addressed, and four of the 48 patients (8.3%) underwent spinal cord detething. This number is similar to the rate of tethering described in the Danzer 2016 3 .
Long-term ambulatory status in prenatal closure of MM patients is unknown. Careful clinical follow-up is necessary to evaluate whether prenatal closure of MM has a sustained benefit for improved ambulation. Although tethered cord syndrome (TCS) has developed in some infants who had fetoscopic closure of MM, it is not clear that the rate of development of TCS is higher as compared to infants whose MM was closed after birth. Long-term analysis of gait and functional ambulation should be monitored in all infants with MM.
FUTURE RESEARCH
Future research is needed to evaluate whether prenatal closure of MM provides long-term benefit to future ambulatory status. An evaluation of the rate of symptomatic spinal cord tethering in both patient populations would be insightful. A good quality RCT with long-term follow up would be ideal. The authors hope that continued follow-up of the patients from the MOMS trial may answer this question in the future. 
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